LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 10.95 | 17.25 | 896 | 471 | 1.9000 | 1.2879 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 10.95 | 17.25 | 3 | 471 | 0.0064 | -0.3069 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 10.95 | 17.25 | 992 | 471 | 2.1036 | 1.3372 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.91 | 17.25 | 19 | 494 | 0.0384 | 0.0201 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.91 | 17.25 | 939 | 494 | 1.8975 | 1.2829 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.91 | 17.25 | 2 | 494 | 0.0040 | -0.3592 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 12.91 | 17.25 | 1043 | 494 | 2.1077 | 1.3329 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.88 | 17.25 | 21 | 534 | 0.0393 | 0.0405 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.88 | 17.25 | 1060 | 534 | 1.9834 | 1.2965 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.88 | 17.25 | 2 | 534 | 0.0037 | -0.3528 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 14.88 | 17.25 | 1127 | 534 | 2.1088 | 1.3251 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.85 | 17.25 | 25 | 655 | 0.0381 | 0.0732 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.85 | 17.25 | 1191 | 655 | 1.8167 | 1.2410 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.85 | 17.25 | 2 | 655 | 0.0031 | -0.3367 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 16.85 | 17.25 | 1276 | 655 | 1.9464 | 1.2706 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 18.82 | 17.25 | 26 | 800 | 0.0325 | 0.0769 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 18.82 | 17.25 | 1315 | 800 | 1.6427 | 1.1876 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 18.82 | 17.25 | 3 | 800 | 0.0037 | -0.2709 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 18.82 | 17.25 | 1400 | 800 | 1.7489 | 1.2125 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 20.79 | 17.25 | 27 | 1001 | 0.0270 | 0.0794 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 20.79 | 17.25 | 1406 | 1001 | 1.4037 | 1.1192 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 20.79 | 17.25 | 2 | 1001 | 0.0020 | -0.3077 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 20.79 | 17.25 | 1506 | 1001 | 1.5035 | 1.1442 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 22.76 | 17.25 | 30 | 1193 | 0.0251 | 0.0947 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 22.76 | 17.25 | 1516 | 1193 | 1.2701 | 1.0798 | MN20160310_N02 | E22 |